tm logo
MEDIGENE
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED

no statement of use filed

on 11 Apr 2022

Last Applicant/ Owned by

Lochhamer Str. 11

Planegg-Martinsried

DE

82152

Serial Number

88347854 filed on 20th Mar 2019

Registration Number

N/A

Correspondent Address

ADRIENNE L. WHITE

WRB-IP LLP

P.O. BOX 476

WADSWORTH OH 44282

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

MEDIGENE

Services in molecular biology, in particular research and development in the field of medical and veterinary diagnosis and treatment using molecular biological, biotechnological and genetic methods, and in the field of screening for compounds with pharmaceutical properties; Development of test methods and test kits; Development of adoptive T cell therapy; Development of DC vaccines; Development ofRead More

Classification Information


Class [044]
Medical, Beauty & Agricultural Services


Cell analyses in the nature of medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical and veterinary medical services, in particular extracting of blood and/or tissue samples and analysis and evaluation relating thereto; Individualized medicine in the nature of medical services; medical services specifically, development of treatment plans for the treatment of tumors and/or neoplastic diseases, hematopoietic tumors, solid tumors; physical therapy adapted for individual patients

Class [042]
Computer & Software Services & Scientific Services


Services in molecular biology, in particular research and development in the field of medical and veterinary diagnosis and treatment using molecular biological, biotechnological and genetic methods, and in the field of screening for compounds with pharmaceutical properties; Development of test methods and test kits; Development of adoptive T cell therapy; Development of DC vaccines; Development of cellular tumour therapy; Development of tumour markers; Development of diagnostic and therapeutic antibodies

Class [005]
Pharmaceutical Products


Pharmaceutical and veterinary preparations, namely, cellular preparations for the treatment of tumours/neoplastic diseases, hematological tumors, more specifically leukemias or lymphomkas, solid tumors; Pharmaceutical T-cell preparations and dendritic cell preparations for the treatment of cancer and use in immunotherapy; medical compositions in the nature of pharmaceutical preparations for the treatment of hematological and solid tumors, tumor precursors; Test kits for diagnostic preparations for medical purposes for determining the type and/or existence of a tumor in a patient consisting primarily of soluble T-cell receptors; test kits for diagnostic preparations for medical purposes for determining the type and/or existence of a tumor in a patient consisting primarily of genetically modified cells; Test kits for diagnostic preparations for medical purposes for determining the type/existence of a tumor in a patient consisting of a composition of antibodies, soluble T-cell receptors and genetically modified cells; Diagnostic and therapeutic preparations for medical purposes being mixtures of therapeutically active cells in a suitable medium, in particular produced using molecular biological, biotechnological and genetic methods

Mark Details


Serial Number

No 88347854

Mark Type

No Service Mark

Attorney Docket Number

No 000337-022

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.03.13 -

Two ovals

26.03.21 -

Ovals that are completely or partially shaded

27.03.01 -

Geometric figures forming letters or numerals, including punctuation

Description of Design Search

The mark consists of the wording "MEDIGENE" in stylized script, where the letter "I" is comprised of two oval shapes.

Legal History


Show more

Status DateAction Taken
11th Apr 2022ABANDONMENT - NO USE STATEMENT FILED
11th Apr 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
15th Sep 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
14th Sep 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
14th Sep 2021SOU EXTENSION 1 GRANTED
07th Sep 2021SOU TEAS EXTENSION RECEIVED
07th Sep 2021SOU EXTENSION 1 FILED
09th Mar 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12th Jan 2021PUBLISHED FOR OPPOSITION
12th Jan 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED